Determination of rifampin in human plasma by high-performance liquid chromatography with ultraviolet detection.
A simple, specific and sensitive high-performance liquid chromatographic (HPLC) method was developed for the determination of rifampin in human plasma. Rifampin and sulindac (internal standard) are extracted from human plasma using a C2 Bond Elut extraction column. A 100-microliter volume of 0.1 M HCl is added to the plasma before extraction to increase the retention of the compounds on the extraction column. Methanol (1 ml) is used to elute the compounds and 0.5 ml of 3 mg/ml ascorbic acid in water is added to the final eluate to reduce the oxidation of rifampin. Separation is achieved by reversed-phase chromatography on a Zorbax Rx C8 column with a mobile phase composed of 0.05 M potassium dihydrogen phosphate-acetonitrile (55:45, v/v). Detection is by ultraviolet absorbance at 340 nm. The retention times of rifampin and internal standard are approximately 4.4 and 7.8 min, respectively. The assay is linear in concentration ranges of 50 to 35 000 ng/ml. The quantitation limit is 50 ng/ml. Both intra-day and inter-day accuracy and precision data showed good reproducibility.
Lau
Y Y
YY
Department of Biopharmaceutics, Corning Hazleton Inc., Madison, WI 53704, USA.
Hanson
G D
GD
Carel
B J
BJ
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000097:blood; D000904:Antibiotics, Antitubercular / Q000097:blood* / Q000493:pharmacokinetics; D002138:Calibration; D002851:Chromatography, High Pressure Liquid; D006801:Humans; D011786:Quality Control; D012293:Rifampin / Q000097:blood* / Q000493:pharmacokinetics; D012996:Solutions; D013056:Spectrophotometry, Ultraviolet; D013467:Sulindac / Q000097:blood
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000904:Antibiotics, Antitubercular; D012996:Solutions; D013467:Sulindac; D012293:Rifampin